Thesis (Ph.D. in Microbiology) -- University of Colorado Denver, 2007. / Typescript. Includes bibliographical references (leaves 183-207). Free to UCD affiliates. Online version available via ProQuest Digital Dissertations;

Thesis (Ph.D.)--University of Alabama at Birmingham, 2009. / Title from PDF title page (viewed on Feb. 3, 2010). Includes bibliographical references.

Cheng, Wai Hang. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2009. / Includes bibliographical references (leaves 76-88). / Abstract also in Chinese. / Acknowledgement --- p.i / 摘要 --- p.iii / List of Abbreviations --- p.iv / List of Figures --- p.vi / List of Tables --- p.vii / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- FE65 --- p.1 / Chapter 1.1.1 --- FE65 Protein Family and Their Structures --- p.2 / Chapter 1.1.1.2 --- PTB domains --- p.5 / Chapter 1.1.2 --- Expression Pattern of FE65 Proteins --- p.6 / Chapter 1.1.3 --- FE65 Family-Transgenic Animals --- p.7 / Chapter 1.1.4 --- Interacting Partners of FE65 --- p.8 / Chapter 1.1.4.1 --- "APP, APLPl and APLP2" --- p.9 / Chapter 1.1.4.2 --- LRP1 and ApoEr2 --- p.10 / Chapter 1.1.4.3 --- c-Abl --- p.11 / Chapter 1.1.4.4 --- Mena and EVL --- p.11 / Chapter 1.1.4.5 --- Tip60 --- p.12 / Chapter 1.1.4.6 --- SET --- p.12 / Chapter 1.1.4.7 --- Estrogen Receptor a --- p.13 / Chapter 1.1.4.8 --- Teashirt --- p.13 / Chapter 1.1.4.9 --- CP2/LSF/LBP1 --- p.13 / Chapter 1.1.4.10 --- Dexra sl --- p.14 / Chapter 1.1.4.11 --- P2X2-receptor subunit --- p.14 / Chapter 1.1.4.12 --- Tau --- p.15 / Chapter 1.1.4.13 --- Notchl --- p.15 / Chapter 1.1.4.14 --- Alcadein --- p.16 / Chapter 1.1.4.15 --- CD95/Fas/Apo -1 ligand --- p.16 / Chapter 1.1.4.16 --- p68 subunit of pre -mRNA cleavage and polyadenylation factor Im (p68 CFIm) --- p.17 / Chapter 1.1.4.17 --- Ataxinl --- p.17 / Chapter 1.1.5.1 --- FE65 as an adaptor protein --- p.20 / Chapter 1.1.5.2 --- FE65 and Alzheimer´ةs disease --- p.20 / Chapter 1.1.5.3 --- Transcriptional / Post-transcriptional regulation --- p.22 / Chapter 1.1.5.4 --- Apoptosis and cell cycle regulation --- p.23 / Chapter 1.1.5.5 --- Neuronal positioning and cell migration --- p.23 / Chapter 1.1.5.6 --- Learning and memory --- p.25 / Chapter 1.2 --- Objectives --- p.26 / Chapter Chapter 2 --- Investigation of the interaction between FE65 and Arf6 --- p.27 / Chapter 2.1 --- Materials --- p.27 / Chapter 2.1.1 --- DNA contructs --- p.27 / Chapter 2.1.2 --- Cell culture --- p.27 / Chapter 2.1.3 --- Immunoblotting --- p.28 / Chapter 2.1.4 --- Miscellaneous --- p.28 / Chapter 2.2 --- Methods --- p.29 / Chapter 2.2.1 --- Preparation of Escherichia coli competent cells --- p.29 / Chapter 2.2.2 --- DNA preparation with Intron Plasmid DNA --- p.30 / Chapter 2.2.3 --- DNA preparation with Macherey-Nagel NucleoBond Xtra Midi --- p.30 / Chapter 2.2.4 --- DNA preparation by the alkaline lysis method --- p.31 / Chapter 2.2.5 --- Spectrophotometric analysis of DNA --- p.32 / Chapter 2.2.6 --- Agarose gel electrophoresis --- p.32 / Chapter 2.2.7 --- Cell culture and transfection --- p.33 / Chapter 2.2.8 --- Bacterial GST-pull down assay --- p.33 / Chapter 2.2.9 --- GST-pull down assay for testing direct interaction between FE65 and Arf6 --- p.34 / Chapter 2.2.10 --- Mammalian GST-pull down assay --- p.35 / Chapter 2.2.11 --- Immunoprecipitation --- p.36 / Chapter 2.2.12 --- SDS-PAGE --- p.36 / Chapter 2.2.13 --- Immunoblotting --- p.39 / Chapter 2.3 --- Results --- p.40 / Chapter 2.3.1 --- Interaction between Arf6 and FE65 --- p.40 / Chapter 2.3.2 --- Determination of the interacting domain of FE65 with Arf6 --- p.43 / Chapter 2.3.3 --- Determination if FE65 and Arf6 interact directly --- p.45 / Chapter Chapter 3 --- Production of Antisera against Arf6 and Immunostaining of FE65-Arf6 --- p.47 / Chapter 3.1 --- Materials --- p.47 / Chapter 3.1.1 --- Protein expression and purification --- p.47 / Chapter 3.1.2 --- Immunization and harvest of antisera --- p.48 / Chapter 3.1.3 --- Immunostaining --- p.48 / Chapter 3.2 --- Methods --- p.48 / Chapter 3.2.1 --- Protein expression and purification --- p.48 / Chapter 3.2.2 --- Bradford assay --- p.50 / Chapter 3.2.3 --- Immunization --- p.50 / Chapter 3.2.4 --- Antibody purification --- p.51 / Chapter 3.2.5 --- Immunostaining --- p.52 / Chapter 3.3 --- Results --- p.53 / Chapter 3.3.1 --- Recombinant Arf6 expression and purification --- p.53 / Chapter 3.3.2 --- Titering of antisera --- p.57 / Chapter 3.3.3 --- Determination of antisera specificity --- p.59 / Chapter Chapter 4 --- Discussion --- p.68 / Chapter Chapter 5 --- Future Perspectives --- p.73 / References --- p.76

Orientador: Celso Eduardo Benedetti / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-16T01:56:52Z (GMT). No. of bitstreams: 1 Souza_TiagoAntoniode_M.pdf: 8040684 bytes, checksum: 0b9836df8d96343f09503df5056436cd (MD5) Previous issue date: 2010 / Resumo: O cancro cítrico, causado pela bactéria Xanthomonas axonopodis pv. citri (Xac), é uma doença que afeta a maioria das espécies do gênero Citrus, ocorrendo praticamente em todos os continentes, e se destaca como uma das ameaças à citricultura brasileira. O mecanismo molecular pelo qual Xac causa o cancro não é inteiramente conhecido, entretanto, sabe-se que a bactéria ao infectar a planta, utiliza o sistema secretório tipo ??? (TTSS) para injetar proteínas de patogenicidade, entre elas PthAs da família AvrBs3/PthA. Quando expresso na célula hospedeira, PthA induz lesões características do cancro como hipertrofia e hiperplasia. Estudos recentes demonstram que membros dessa família atuam como fatores de transcrição. Portanto, a elucidação de como PthA ativa a transcrição é de grande importância para o entendimento do seu mecanismo de ação e desenvolvimento das lesões do cancro. Neste contexto, o presente projeto teve como objetivo caracterizar interações entre a proteína PthA de Xac e as proteínas CsARF (Auxin Response Factor) e CsHMG (High-mobility group) de laranja doce (Citrus sinensis), previamente identificadas em ensaios de duplo híbrido de leveduras. CsARF tem elevada similaridade com AtARF2, um repressor transcricional envolvido na via de sinalização por auxinas. Hormônios vegetais desempenham um importante papel na interação planta-patógeno e em nosso laboratório verificamos que auxinas são importantes para o desenvolvimento dos sintomas do cancro. CsARF foi capaz de interagir com a maioria das variantes de PthA tanto in vitro quanto em ensaios de duplo-híbrido de leveduras. A interação de CsARF com PthA se dá através dos domínios C-terminal Aux/IAA e B3 de ligação ao DNA. Verificamos que o promotor do gene de uma expansina de citros, induzido por Xac e auxina, apresenta possíveis sítios de ligação das proteínas CsARF e PthA. Dados de EMSA indicam que PthA e CsARF ligam em sítios adjacentes no promotor da expansina de citros e que a interação de PthA com CsARF poderia deslocá-la do promotor. A proteína CsHMG é semelhante a AtHMGB1 de Arabidopsis thaliana, envolvida em crescimento celular. CsHMG interagiu com todas as variantes de PthA, sendo que essa interação envolve uma região rica em leucinas (LRR), idêntica nas quatro variantes de PthA. Verificou-se também que CsHMG é capaz de ligar DNA de forma inespecífica. Por outro lado, CsHMG ligou RNA in vitro, com especificidade para RNAs ricos em uridina (poly-U). Como PthA age como fator de transcrição eucarioto, não é surpreendente que proteínas do hospedeiro envolvidas com regulação gênica sejam capazes de interagir com esse efetor, sugerindo um novo modo de ação de proteínas efetoras bacterianas. / Abstract: Citrus canker disease, caused by Xanthomonas axonopodis pv. citri (Xac), affects almost all citrus species and represents a major threat to the Brazilian citriculture. The molecular mechanism by which Xac causes citrus canker disease is poorly understood, however the bacterium injects pathogenicity proteins through a type III secretion system (TTSS) including proteins of AvrBs3/PthA family proteins. When transiently expressed in host cells, PthAs alter transcription of the host cell to the benefit of the pathogen, leading to the development of the cancer lesions, including hypertrophy and hyperplasia. These proteins are thought to acts as eukaryotic transcriptional factors, binding and activating directly promoters of host genes. Therefore, elucidating how activates PthA transcription is very important to understanding the mechanisms governing the development of canker lesions. To elucidate how PthA activates transcription and to establish its molecular mode of action, a two-hybrid approach was used to identify host proteins that interact with PthA and therefore could be important for the development of the canker lesions. Among the citrus proteins identified, we selected for studies a CsARF (Auxin Response Factor) and a CsHMG (High-mobility group), both involved in regulation of gene transcription. CsARF shares high similarity to the Arabidopsis thaliana ARF2, involved in the auxin signaling pathway. This is in line with our previous studies showing that auxin is required for canker development. The interactions between all variants of PthA were analyzed both in vivoand in vitro and depend on the repeat domain of PthAs. The B3 DNA binding and the Aux/IAA domains of CsARF are both involved in protein-protein interactions. Interestingly, the citrus promoter of a citrus expansin gene that is up-regulated by Xac and auxin contains putative CsARF and PthA binding sites. Since these sites are located adjacent in this promoter, it is suggested that the interaction of PthA with CsARF might somehow affect the regulation of the expansin promoter. CsHMG is highly similar to the A. thaliana HMGB1 involved in cell growth. CsHMG interacts with all PthA variants and its interaction was shown to be mediated primarly by the leucine-rich repeat (LRR) region of PthAs. CsHMG binds to DNA in a non-specific fashion; surprisingly, however, CsHMG shows an as yet unreported ability to bind to synthetic RNA forms with an apparent specificity to poly-U probes. PthA acts like an eukaryotic transcription factor and is not surprising that host proteins involved with gene regulation can interact with this effector, suggesting a new mode of action of these bacterial effector proteins. / Mestrado / Genetica Vegetal e Melhoramento / Mestre em Genética e Biologia Molecular

ARF, a potent tumor suppressor, positively regulates p53 by antagonizing MDM2, a negative regulator of p53, which in turn, results in either apoptosis or cell cycle arrest. ARF also suppresses the proliferation of cells lacking p53, and loss of ARF in p53-null mice, compared with ARF-null or p53-null mice, results in a broadened tumor spectrum and decreased tumor latency. This evidence suggests that ARF exerts both p53-dependent and p53-independent tumor suppressor activity. However, the molecular pathway and mechanism of ARF’s p53-independent tumor suppressor activity is not understood. The antiapoptotic, metabolically regulated, transcriptional corepressor C-terminal binding protein 2 (CtBP2) has been identified as a specific target of ARF’s p53-independent tumor suppression. CtBPs are phosphoproteins with PLDLS-binding motif and NADH-binding central dehydrogenase domains. ARF interacts with CtBP1 and CtBP2 both in vitro and in vivo, and induces their proteasome-mediated degradation, resulting in p53-independent apoptosis in colon cancer cells. ARF’s ability to target CtBP2 for degradation, and its induction of p53-independent apoptosis requires an intact interaction with CtBP2, and phosphorylation at S428 of CtBP2. As targets for inhibition by ARF, CtBPs are candidate oncogenes, and their expression is elevated in a majority of human colorectal adenocarcinomas specimens in comparison to normal adjacent tissue. Relevant to its targeting by ARF, there is an inverse correlation between ARF and CtBP expression, and CtBP2 is completely absent in a subset of colorectal adenocarcinomas that retains high levels of ARF protein. CtBPs are activated under conditions of metabolic stress, such as hypoxia, and they repress epithelial and proapoptotic genes. BH3-only genes such as Bik, Bim and Bmf have been identified as mediators of ARF-induced, CtBP2-mediated p53-indpendent apoptosis. CtBP2 repressed BH3-only genes in a tissue specific manner through BKLF (Basic kruppel like factor)-binding elements. ARF regulation of BH3-only genes also required intact interaction with CtBP2. ARF antagonism of CtBP repression of Bik and other BH3-only genes may play a critical role in ARF-induced p53-independent apoptosis, and in turn, tumor suppression. To study the physiologic effect of ARF/CtBP2 interaction at the organismal level, the p19ArfL46D knock-in mice, in which the Arf/CtBP2 interaction was abrogated, was generated. Analysis of the primary cells derived from these mice, revealed that the Arf/CtBP2 interaction contributes to regulation of cell growth and cell migration. Overexpression of CtBP in human tumors, and ARF antagonism of CtBP repression of BH3-only gene expression and CtBP-mediated cell migration may therefore play a critical role in the p53-independent tumor suppressor function/s of ARF.

Vesicle budding, membrane trafficking, and lipid metabolism depend on the switching of Arf and Rab GTPases from the inactive GDP bound state to the active GTP bound state. However, Arf and Rab GTPases have intrinsic rates of GDP to GTP exchange that are much slower (hours to days) than the time scale of the relevant trafficking processes (seconds or less). In cells, the activation of Arf and Rab GTPases is tightly regulated by guanine nucleotide exchange factors (GEFs) with Sec7 or Vps9 domains, respectively. Full length Cytohesins, which have a domain architecture consisting of heptad repeats, a Sec7 domain, a pleckstrin homology (PH) domain, and a polybasic motif, have 100-fold lower exchange activity than the isolated Sec7 domain. Insights into the low exchange activity were obtained by structural, biochemical and kinetic analyses. It was found that the Sec7-PH domain linker and a C-terminal amphipathic helix physically block the docking sites for the switch regions of Arf GTPases. Mutations within either element result in partial or complete relief of autoinhibition. Autohibition is also strongly relieved by phosphorylation of protein kinase C (PKC) sites in the polybasic motif of Cytohesin-1 or by phosphoinositide head group-dependent binding of active Arf6. Despite unrelated folds, Sec7 and Vps9 domains engage cognate GTPases in a strikingly similar manner and supply a critical acidic residue that interacts with an invariant lysine residues from phosphate binding (P) loop of the GTPase in the nucleotide free complex. The key acidic residues have also been proposed to disrupt the Mg2+ binding site; however, it is not known whether disruption of Mg2+ binding contributes to the rate limiting step for nucleotide release. To investigate the kinetic mechanism for catalysis of nucleotide exchange in the absence of autoinhibitory interactions, a detailed stopped flow kinetic analysis of the intrinsic and GEF mediated exchange reactions was conducted for the isolated catalytic cores. Using three different fluorescence methods to monitor Mg2+ dissociation, formation of the nucleotide free intermediate, and subsequent nucleotide binding, the catalytic cores of Cytohesin-1 and Rabex-5 were found to robustly accelerate nucleotide exchange on Arf1 and Rab5, respectively, by at least 105- fold at physiological concentrations of Mg2+. The acceleration of nucleotide exchange was reduced by roughly an order of magnitude at sub-micromolar concentrations of Mg2+. In addition, the Cytohesin-1 and Rabex-5 catalytic cores have similarly high catalytic efficiencies (kcat/KM) as well as high lower limits on both the rate (kcat) and steady state (KM) constants for GDP release at physiological as well as low Mg2+ concentration. The limits on kcat and KM are comparable to the highest values reported for other well characterized GEFs and likely reflect dual requirements of membrane targeting and autoregulatory mechanisms for tight control of catalytic output. These results provide a solid structural and mechanistic foundation for future experiments to investigate the spatial-temporal dynamics of Cytohesin and Rabex-5 activation in cellular contexts.